Your session is about to expire
← Back to Search
Other
Low-Salt Diet for Rheumatoid Arthritis
N/A
Waitlist Available
Led By Charles M Stein, MBChB
Research Sponsored by Vanderbilt University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Have moderate disease activity as reflected by a minimum of 3 swollen and tender joints.
Be older than 18 years old
Must not have
Organ or bone marrow transplant
Taking diuretics, uncontrolled hypertension (>160/100 mmHg), or cardiac failure requiring treatment.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up will be measured at beginning and end of each diet period at weeks 0,8 and 12, 20
Awards & highlights
No Placebo-Only Group
Summary
This trial will test whether reducing dietary sodium intake can help manage RA by reducing inflammation, blood pressure, and tissue sodium levels.
Who is the study for?
This trial is for adults over 18 with rheumatoid arthritis who meet specific diagnostic criteria, have stable disease activity without recent changes in medication, and at least 3 swollen and tender joints. It's not for those with recent major surgery, uncontrolled high blood pressure, severe edema, diabetes on an insulin pump, or conditions making blood pressure monitoring difficult.
What is being tested?
The study tests if reducing dietary salt can lower inflammation and blood pressure in rheumatoid arthritis patients. It also looks at whether less salt affects tissue sodium levels. Participants will follow a low-sodium diet to see these potential effects.
What are the potential side effects?
While the trial involves dietary changes rather than medication, possible side effects may include altered taste preference, mild discomfort from diet adjustment or cravings for salty foods. No significant medical side effects are expected.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have at least 3 swollen and tender joints.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have had an organ or bone marrow transplant.
Select...
I am taking diuretics, have high blood pressure (>160/100 mmHg), or need treatment for heart failure.
Select...
I manage my diabetes with an insulin pump.
Select...
I am currently on dialysis.
Select...
I have not had major surgery in the last 3 months.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ will be measured at beginning and end of each diet period at weeks 0,8 and 12, 20
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~will be measured at beginning and end of each diet period at weeks 0,8 and 12, 20
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Tissue sodium
Secondary study objectives
Change in DAS 28
Change in blood pressure
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: low salt dietExperimental Treatment1 Intervention
low-sodium diet (50mmol/24hours x 8 weeks ) Subjects will choose a rotation of low-sodium meals from a predetermined list from a commercial vendor (Mom's Meals) that will be used to provide 2 meals (lunch and dinner)/day that the vendor will deliver at approximately 7 day intervals. Staff of the Vanderbilt Diet,Body Composition, and Human Metabolism Core determine breakfast and snacks appropriate for theHS andLS diets and provide instructions to subjects.
Group II: high salt dietExperimental Treatment1 Intervention
high-sodium diet (200mmol/24hours x 8weeks) Subjects will choose a rotation of low-sodium meals from a predetermined list from a commercial vendor (Mom's Meals) that will be used to provide 2 meals (lunch and dinner)/day that the vendor will deliver at approximately 7 day intervals. Staff of the Vanderbilt Diet,Body Composition, and Human Metabolism Core determine breakfast and snacks appropriate for theHS andLS diets and provide instructions to subjects.
Find a Location
Who is running the clinical trial?
Vanderbilt University Medical CenterLead Sponsor
901 Previous Clinical Trials
938,660 Total Patients Enrolled
1 Trials studying Rheumatoid Arthritis
32 Patients Enrolled for Rheumatoid Arthritis
National Institutes of Health (NIH)NIH
2,811 Previous Clinical Trials
8,161,216 Total Patients Enrolled
9 Trials studying Rheumatoid Arthritis
626 Patients Enrolled for Rheumatoid Arthritis
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,931 Previous Clinical Trials
47,766,686 Total Patients Enrolled
5 Trials studying Rheumatoid Arthritis
1,013 Patients Enrolled for Rheumatoid Arthritis
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have had an organ or bone marrow transplant.I do not have severe health issues that could affect my participation.I am taking diuretics, have high blood pressure (>160/100 mmHg), or need treatment for heart failure.I manage my diabetes with an insulin pump.I am willing and able to follow study requirements.I have severe swelling as determined by my doctor.You are pregnant.I am currently on dialysis.I have at least 3 swollen and tender joints.I am over 18 years old and willing to participate.My medication for immune system or steroids hasn't changed in the last month.I have not had major surgery in the last 3 months.You are unable to undergo an MRI for medical reasons.
Research Study Groups:
This trial has the following groups:- Group 1: low salt diet
- Group 2: high salt diet
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger